产品介绍：
产品说明
组分
Contains 10 mg each of the glycolysis and gluconeogenesis pathway metabolite standards packaged individually.
产品性质
| 储存温度 | −20℃ |
组份列表
组份可单独销售
| 货号 | 组份 |
| 158968 | α- |
| B4501 | Biotin, ≥99% (HPLC), lyophilized powder 10 mg |
| D7137 | Dihydroxyacetone phosphate dilithium salt, ≥93% (enzymatic) 10 mg |
| F3627 | |
| F6803 | |
| G6750 | α- |
| G7127 | Guanosine 5′-diphosphate sodium salt, Type I, ≥96% (HPLC) 10 mg |
| G7528 | |
| G7879 | |
| G8877 | Guanosine 5′-triphosphate sodium salt hydrate, ≥95% (HPLC), powder 10 mg |
| K1750 | α-Ketoglutaric acid, ≥98.5% (NaOH, titration) 10 mg |
| L1750 | |
| M8304 | Malic acid, meets USP/NF testing specifications 10 mg |
| O7753 | Oxaloacetic acid, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥97% (HPLC) 10 mg |
| P2256 | Sodium pyruvate, ReagentPlus®, ≥99% 15 mg |
| P7127 | Phospho(enol)pyruvic acid monopotassium salt, ≥97% (enzymatic) 10 mg |
| P8877 |
安全信息
| 象形图 |    |
| 警示用语： | Danger |
| 危险声明 | H315 - H317 - H318 - H335 - H371 |
| 预防措施声明 | P260 - P264 - P280 - P302 + P352 - P305 + P351 + P338 - P308 + P311 |
| 危险分类 | Eye Dam. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 2 - STOT SE 3 |
| 靶器官 | Respiratory system |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
